Capital City Trust’s GSK GSK Stock Holding History

Capital City Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-745	Closed	-$47K	–	139
2013 Q2	$47K	Buy	+745	New	+$47.3K	0.02%	119

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Capital City Trust's GSK Position: Q3 2013 in Review

Capital City Trust sold out of GSK (GSK) in Q3 2013, closing a stake of 745 shares — an estimated $47K sold.

Capital City Trust first reported a position in GSK in Q2 2013 and held it in 1 quarter. The position peaked at $47K in Q2 2013. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

Capital City Trust reported no remaining GSK position as of Q3 2013 after selling out during the quarter.
Capital City Trust sold 745 GSK shares in Q3 2013, an estimated $47K.
Capital City Trust first reported a position in GSK in Q2 2013 and held it in 1 quarter.
Capital City Trust's GSK position peaked at $47K in Q2 2013.
635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Capital City Trust's 13F filing for Q3 2013, filed 12 Nov 2013.